{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:12Z","timestamp":1791496692648,"version":"4.3.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, has demonstrated efficacy in the management of type 2 diabetes mellitus (T2DM). This study aimed to investigate the effects of sitagliptin on gut microbial composition and gut barrier integrity in a streptozotocin (STZ)-induced rat model of T2DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sprague-Dawley rats were randomly divided into four groups (<jats:italic>n<\/jats:italic> = 6 per group): a T2DM group induced by high-fat diet (HFD) and STZ injection; a T2DM group treated with oral sitagliptin at 10 mg\/kg\/day for 12 weeks (T2DM-Sit); a normal diet control group (ND); and a normal diet group treated with sitagliptin (ND-Sit). Fecal samples were collected for 16S rRNA gene sequencing to analyze gut microbial composition and diversity. Intestinal tissues were assessed for tight junction protein expression via immunohistochemistry and western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Alpha index metrics, including observed feature number and Shannon index, were significantly decreased in the T2DM group compared to the ND group. Sitagliptin treatment led to a significant restoration of these indices. Principal coordinate analysis based on Bray-Curtis distances revealed distinct clustering between the ND and T2DM groups, with sitagliptin shifting the microbial profile of diabetic rats toward that of healthy controls. Sitagliptin treatment increased the relative abundance of <jats:italic>Lactobacillus, Ruminococcus, Streptococcus, Klebsiella, Clostridium_IV<\/jats:italic>, and <jats:italic>Romboutsia<\/jats:italic>, while reducing levels of <jats:italic>Alloprevotella<\/jats:italic> and <jats:italic>Parasutterella<\/jats:italic>, effectively reversing the dysbiotic changes observed in T2DM. Additionally, sitagliptin modulated microbial metabolic pathways, restructured the gut microbial network, and promoted short-chain fatty acid production. Histological and western blot analysis revealed enhanced expression of the tight junction protein ZO-1 and increased numbers of mucin-secreting goblet cells, indicating improved gut barrier integrity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Sitagliptin effectively ameliorates gut microbial dysbiosis and restores intestinal barrier function in STZ-induced T2DM rats. These findings provide novel insights into the gut-related therapeutic effects of sitagliptin and underscore its potential in restoring gut homeostasis in T2DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2025.1655522","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:32:44Z","timestamp":1758274364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Sitagliptin ameliorates microbial dysbiosis and enhances gut barrier integrity in streptozotocin-induced type 2 diabetic rats"],"prefix":"10.3389","volume":"16","author":[{"given":"Ying","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"761834","DOI":"10.3389\/fendo.2021.761834","article-title":"Therapeutic potential of butyrate for treatment of Type 2 Diabetes","volume":"12","author":"Arora","year":"2021","journal-title":"Front. Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr. Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2106103","DOI":"10.1080\/19490976.2022.2106103","article-title":"Modeling spatial interaction networks of the gut microbiota","volume":"14","author":"Cao","year":"2022","journal-title":"Gut Microbes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/s41467-020-17840-y","article-title":"Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2118811","DOI":"10.1001\/jamanetworkopen.2021.18811","article-title":"Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13099-021-00446-0","article-title":"Gut microbiota influence in type 2 diabetes mellitus (T2DM)","volume":"13","author":"Cunningham","year":"2021","journal-title":"Gut Pathog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1084702","DOI":"10.3389\/fnut.2022.1084702","article-title":"Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes","volume":"9","author":"Fernandez-Quintela","year":"2023","journal-title":"Front Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e7117","DOI":"10.7717\/peerj.7117","article-title":"Effect of heat-killed Streptococcus thermophilus on type 2 diabetes rats","volume":"7","author":"Gao","year":"2019","journal-title":"PeerJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4216702","article-title":"Microbial network signatures of early colonizers in infants with eczema","author":"Huang","year":"2023","journal-title":"iMeta"},{"key":"B17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders","volume":"9","author":"Kelly","year":"2015","journal-title":"Front. Cell Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tim.2016.11.008","article-title":"Disentangling Interactions in the microbiome: a network perspective","volume":"25","author":"Layeghifard","year":"2017","journal-title":"Trends Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13099-020-00370-9","article-title":"Understanding horizontal gene transfer network in human gut microbiota","volume":"12","author":"Li","year":"2020","journal-title":"Gut Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12864-023-09805-4","article-title":"Metagenomic analysis reveals distinct changes in the gut microbiome of obese Chinese children","volume":"24","author":"Li","year":"2023","journal-title":"BMC Genomics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ebiom.2019.03.057","article-title":"Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis","volume":"44","author":"Liao","year":"2019","journal-title":"EBioMedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.3892\/etm.2016.3255","article-title":"Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-\u03baB pathway inhibition","volume":"11","author":"Lin","year":"2016","journal-title":"Exp. Therap. Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","article-title":"SCFA: mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc, Nutr. Soc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"114838","DOI":"10.1016\/j.physbeh.2025.114838","article-title":"The role of gut microbiota and bacterial translocation in the pathogenesis and management of type 2 diabetes mellitus: Mechanisms, impacts, and dietary therapeutic strategies","volume":"293","author":"Murugesan","year":"2025","journal-title":"Physiol. Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41401-020-0413-7","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2","volume":"41","author":"Ning","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"B26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J. Nutr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13073-021-00851-9","article-title":"Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark","volume":"13","author":"Pinna","year":"2021","journal-title":"Genome Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-20-0473e","article-title":"Gut microbiome, endocrine control of gut barrier function and metabolic diseases","volume":"248","author":"R\u00e9gnier","year":"2021","journal-title":"J. Endocrinol"},{"key":"B32","first-page":"639","article-title":"Incretin agents in type 2 diabetes","volume":"56","author":"Ross","year":"2010","journal-title":"Can. Fam. Physician"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00592-021-01727-5","article-title":"The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre","volume":"58","author":"Salamone","year":"2021","journal-title":"Acta Diabetol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ. Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s44154-023-00098-x","article-title":"Unbalanced diets enhance the complexity of gut microbial network but destabilize its stability and resistance","volume":"3","author":"Sun","year":"2023","journal-title":"Stress Biology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"154733","DOI":"10.1016\/j.phymed.2023.154733","article-title":"Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism","volume":"113","author":"Tawulie","year":"2023","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1002\/dmrr.3213","article-title":"Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials","volume":"36","author":"Tiderencel","year":"2020","journal-title":"Diabet. Metabol. Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fmicb.2018.01953","article-title":"Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","article-title":"Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl Environ. Microbiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1002\/imt2.32","article-title":"ggClusterNet: An R package for microbiome network analysis and modularity-based multiple network layouts","volume":"1","author":"Wen","year":"2022","journal-title":"iMeta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","article-title":"The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study","volume":"32","author":"Wu","year":"2020","journal-title":"Cell Metabol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1039\/C9FO01062A","article-title":"Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice","volume":"10","author":"Yan","year":"2019","journal-title":"Food Funct"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2093171","DOI":"10.1155\/2016\/2093171","article-title":"Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study","volume":"2016","author":"Yan","year":"2016","journal-title":"J Diabetes Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/jdi.14157","article-title":"Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor\/gut microbiome crosstalk suggests novel therapeutic options for diabetes management","volume":"15","author":"Yasuda","year":"2024","journal-title":"J. Diabet. Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0203223","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"mBio"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjdrc-2019-000717","article-title":"Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats","volume":"7","author":"Zhang","year":"2019","journal-title":"BMJ Open Diabet. Res. Care"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1655522\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:32:45Z","timestamp":1758274365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1655522\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":47,"alternative-id":["10.3389\/fmicb.2025.1655522"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1655522","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1655522"}}